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Abstract. 
 
We have shown previously that the ADP-
ribosylation factor (ARF)-6 GTPase localizes to the 
plasma membrane and intracellular endosomal com-
partments. Expression of ARF6 mutants perturbs en-
dosomal trafficking and the morphology of the periph-
eral membrane system. However, another study on the 
distribution of ARF6 in subcellular fractions of Chinese 
hamster ovary (CHO) cells suggested that ARF6 did 
not localize to endosomes labeled after 10 min of horse-
radish peroxidase (HRP) uptake, but instead was 
uniquely localized to the plasma membrane, and that its 
reported endosomal localization may have been a re-
sult of overexpression. Here we demonstrate that at the 
lowest detectable levels of protein expression by cry-
oimmunogold electron microscopy, ARF6 localized 
predominantly to an intracellular compartment at the 
pericentriolar region of the cell. The ARF6-labeled ves-
icles were partially accessible to HRP only on pro-
longed exposure to the endocytic tracer but did not lo-
calize to early endocytic structures that labeled with 
HRP shortly after uptake. Furthermore, we have 
shown that the ARF6-containing intracellular compart-
ment partially colocalized with transferrin receptors 
and cellubrevin and morphologically resembled the re-
cycling endocytic compartment previously described in 
CHO cells. HRP labeling in cells expressing ARF6(Q67L), 
a GTP-bound mutant of ARF6, was restricted to small 
peripheral vesicles, whereas the mutant protein was en-
riched on plasma membrane invaginations. On the 
other hand, expression of ARF6(T27N), a mutant of 
ARF6 defective in GDP binding, resulted in an accu-
mulation of perinuclear ARF6-positive vesicles that 
partially colocalized with HRP on prolonged exposure 
to the tracer. Taken together, our findings suggest that 
ARF activation is required for the targeted delivery of 
ARF6-positive, recycling endosomal vesicles to the 
plasma membrane.
 
V
 
esicular
 
 transport along the endocytic and bio-
synthetic pathways is essential for the biogenesis
and maintenance of subcellular organelle integrity
and the trafficking of proteins and lipids within the cell
and between the cell and its extracellular environment.
Along the endocytic pathway, a variety of macromolecules
are internalized via clathrin-dependent or -independent
mechanisms into early endocytic vesicles (reviewed in
Sandvig and Van Deurs, 1994; Gruenberg and Maxfield,
1995; Lamaze and Schmid, 1996; Mellman, 1996), from
which they are delivered to tubulovesicular sorting endo-
somes (Geuze et al., 1983, 1987; Griffiths et al., 1989;
Gruenberg et al., 1989). At this junction, lysosomal pro-
teins are sorted from those proteins that recycle via an it-
erative process in which lysosome-targeted ligands accu-
mulate in the sorting compartment and are then delivered
to lysosomes (Stoorvogel et al., 1991; Dunn et al., 1989;
van Deurs, 1993). On the other hand, recycling markers
are delivered to a pericentriolar recycling compartment
before they are transported back to the plasma membrane
(Hopkins and Trowbridge, 1983; Yashimoro et al., 1984;
Hopkins et al., 1994; Marsh et al., 1995). Although consid-
erable efforts have been made in delineating the general
features of the endocytic pathway, the mechanisms that
regulate these transport pathways are still incompletely
understood and have been the subject of active research.
The vectorial transfer of membrane between intracellu-
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lar membrane-bound endocytic organelles involves a se-
ries of tightly regulated membrane budding and fusion
events. The regulatory machinery includes several cytoso-
lic and membrane-bound GTP-binding proteins (or GTP-
ases) that function as molecular switches cycling between
their GTP- and GDP-bound states. Members of the Rab
GTPase family of the Ras superfamily of low molecular
mass GTPases, have been implicated in the control of var-
ious steps along the endocytic pathway. Rab4 appears to
play a role in recycling of ligands from the sorting endo-
some, bypassing the recycling endosome (van der Sluijs et al.,
1992; Daro et al., 1996), Rab5 has been localized to, and
promotes fusion of, early endosomes (Bucci et al., 1992;
Barbieri et al., 1994), whereas Rab11 has been thought to
regulate transport between sorting and recycling endo-
somes (Ulrich et al., 1996).
In addition to the Rab GTPases, it is well documented
that the ADP-ribosylation factor (ARF)
 
1
 
 GTPases are re-
quired for maintaining the integrity of organelle structure
and intracellular transport. As with the GTPases of the
Rab family, it is likely that the different ARF proteins may
control membrane trafficking from the organelles to which
they are localized. The ARF proteins were originally iden-
tified as cofactors required for cholera toxin catalyzed ADP
ribosylation of Gs (Kahn and Gilman, 1986). The ARF
family currently includes five structurally homologous pro-
teins (ARFs 1, 3, 4, 5, and 6) whose structure is well con-
served across the species (Tsuchiya et al., 1991). The best-
characterized ARF protein, ARF1, is localized to the Golgi
complex (Peters et al., 1995). It is required for the binding
of coat proteins, COP I and the AP1–clathrin complex, to
Golgi membranes, a process critical for maintaining the in-
tegrity of Golgi structure and for vesicle transport along
the biosynthetic pathway (reviewed in Rothman, 1994;
Bowman and Kahn, 1995; Donaldson and Klausner, 1994;
Moss and Vaughan, 1995). The ARFs have been shown to
activate phospholipase D (Brown et al., 1993; Cockroft et
al., 1994; Massenburg et al., 1994). It has been speculated
that ARF-mediated effects on lipid metabolism may relate
to its function in maintaining organelle structure and
transport, and although some studies have implied that a
connection between these functions may indeed exist (Kahn
et al., 1995; Liscovitch and Cantley, 1995; Ktistakis, 1996),
the exact mechanism involved remains unclear.
Our previous studies have shown that ARF6, the least
conserved ARF protein, is localized to the cell periphery
and cycles between the plasma membrane and an intracel-
lular endosomal compartment depending on its nucleotide
status (D’Souza-Schorey et al., 1995; Peters et al., 1995).
Unlike ARF1, the cellular distribution of ARF6 appears
to be insensitive to brefeldin A (Peters et al., 1995). Ex-
pression of mutant forms of ARF6 defective in GTP bind-
ing and hydrolysis in CHO cells has a pronounced effect
on receptor-mediated endocytic trafficking. A mutant form
of ARF6, defective in GTP hydrolysis and hence locked in
its GTP-bound conformation, ARF6(Q67L), is localized
almost exclusively to the plasma membrane and its expres-
sion decreases the rate of uptake of transferrin (D’Souza-
Schorey et al., 1995). Conversely, the dominant negative
and GDP-bound mutant of ARF6, ARF6(T27N), is local-
ized to intracellular compartments (D’Souza-Schorey et al.,
1995; Peters et al., 1995), and its expression results in an
intracellular accumulation of transferrin receptors and an
inhibition of recycling of ligands to the cell surface. These
alterations in endocytic trafficking are accompanied by gross
alterations in the morphology of the peripheral membrane
system (Peters et al., 1995). Expression of wild-type ARF6
and its GTPase-defective mutant, ARF6(Q67L), results in
the elaboration of the plasma membrane, characterized by
the formation of extensive membrane invaginations. On the
other hand, expression of the ARF6(T27N) mutant results
in the massive accumulation of intracellular vesicles that
exhibit a novel coat structure on the cytoplasmic surface.
In addition to eliciting a redistribution of peripheral mem-
brane, the expression of ARF6(Q67L) has also been
shown to induce a remodeling of the actin cytoskeleton
(Radhakrishna et al., 1996; D’Souza-Schorey et al., 1997).
Whether these two cellular activities of ARF6 are code-
pendent processes or are controlled by divergent signaling
pathways remains to be established. In a separate study,
Cavenagh et al. (1996) investigated the distribution of
ARF6 in CHO cells by analysis of subcellular fractions
generated by free flow electrophoresis, wherein the early
endosome fraction was defined by its accessibility to HRP.
They reported that ARF6 localized exclusively to the plasma
membrane and that the previously reported intracellular
localization of ARF6 may have been a consequence of high
levels of protein expression (Cavenagh et al., 1996). In a
more recent study, endogenous ARF6 has been shown to
cofractionate with chromaffin granules in adrenal chroma-
ffin cells (Galas et al., 1997). Triggering of exocytosis re-
sulted in the dissociation of ARF6 from the granule frac-
tion onto an unidentified membrane compartment. Based
on the above, an understanding of the precise compart-
ments to which ARF6 is localized will be pivotal to eluci-
date its biological role.
In this study, by use of the high resolution technique of
cryoimmunogold electron microscopy, we have under-
taken a further characterization of the membrane alter-
ations induced by expression of wild-type ARF6 and its
GTP- and GDP-bound mutants in CHO cells. These stud-
ies have revealed that at low levels of protein expression,
wild-type ARF6 localizes predominantly to intracellular
compartments around the pericentriolar region of the cell
juxtaposed to the TGN. This compartment colocalized
with transferrin receptors and with cellubrevin, a member
of the v-SNARE family of proteins that has been shown to
play a role in membrane recycling (Galli et al., 1994). Fur-
thermore, we have analyzed the distribution of ARF6 and
its mutants relative to the endocytic tracer, HRP. We show
that a small fraction of wild-type ARF6 and its mutant de-
fective in GTP-binding, ARF6(T27N), colocalize with HRP
only after prolonged exposure to the tracer. ARF6(Q67L),
the GTP-bound mutant, localizes to the plasma membrane
and HRP labeling in cells expressing this mutant was re-
stricted to small peripheral vesicles. Our findings indicate
that ARF6 is localized to a recycling compartment and may
serve to regulate the outward flow of recycling membrane.
 
1. 
 
Abbreviations used in this paper:
 
 ARF, ADP-ribosylation factor; Tfn-R,
transferrin receptor; HA, hemagglutinin; MPR, cation-dependent man-
nose-6-phosphate receptor; LAMP, lysosome-associated membrane pro-
tein; PLD, phospholipase D; PIP2, phosphatidylinositol 4,5, bisphosphate;
SNARE, soluble NSF attachment protein (SNAP) receptor; VAMP, vesi-
cle-associated membrane protein. 
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Materials and Methods
 
Cells, Reagents, and Antibodies
 
TRVb-1 cells, a CHO cell line that overexpresses transferrin receptors
(McGraw et al., 1987), were grown and maintained in Hams F12 medium
(GIBCO BRL, Gaithersburg, MD), supplemented with 5% fetal bovine
serum, penicillin/streptomycin, and 100 
 
m
 
g/ml G418. HRP-FITC was ob-
tained from Sigma Chemical Co. (St. Louis, MO) and rhodamine-transfer-
rin was kindly provided by Richard Roberts (Washington University, St.
Louis, MO). For the studies described, the following antibodies were used:
affinity-purified polyclonal antisera directed against a COOH-terminal
ARF6 peptide (D’Souza-Schorey et al., 1995); anti-HRP mouse mono-
clonal antibody (Sigma Chemical Co.); antibiotin mouse monoclonal anti-
body (Rockland, Inc., Gilbertsville, PA); anti–lysosome–associated mem-
brane protein (LAMP)-3 (CD63) mouse monoclonal antibody (CLB,
Amsterdam, The Netherlands); antitransferrin receptor H68.4 (generous
gift from Ian Trowbridge, The Salk Institute, San Diego, CA; White et al.,
1992); anti 
 
g
 
-adaptin mouse monoclonal antibody, 100/3 (Sigma Chemical
Co.); anti–LAMP-1 (kindly provided by Minori Fukuda, La Jolla Cancer
Research Institute, La Jolla, CA); anti–mannose-6-phosphate receptor
rabbit polyclonal antisera (kindly provided by Kurt Von Figura, Univer-
sity of Göttingen, Göttingen, Germany); rabbit antisera against 
 
b
 
-COP
(generous gift from Jennifer Lippincott-Schwartz, National Institutes of
Health, Bethesda, MD); and affinity-purified anti-cellubrevin rabbit anti-
sera, MC16 (kindly provided by Thierry Galli, Curie Institute, Paris,
France; Galli et al., 1994).
 
Expression of ARF6 Proteins
 
ARF6 and its mutants were expressed in TRVb-1 cells using the Sindbis
virus as an expression vector. Recombinant virus encoding ARF6 and its
mutant derivatives were generated as previously described (D’Souza-
Schorey et al., 1995). A virus titer of 50 plaque-forming units/cell was used
for cell infection. Adsorption was conducted at room temperature for 1 h
in 250 
 
m
 
l PBS containing 1% FBS. The infection mixtures were replaced
by 2 ml Hams F12 medium containing 3% FBS and cells were maintained
at 37
 
8
 
C. Experiments were carried out 4–5 h after infection. The above
procedure allowed us to examine ARF6 localization at varying levels of
protein expression. Six batches of infected cells were analyzed for localiza-
tion of each ARF protein.
 
Cell Surface Biotinylation
 
Cell monolayers in 35-mm dishes were cooled to 4
 
8
 
C and rinsed with 2 ml
of ice-cold PBS containing 5 mM glucose. The cells were then incubated
with 1 mg/ml sulpho-NHS-biotin (Pierce Chemical Co., Rockford, IL) for
30 min at 4
 
8
 
C. After biotinylation, the cells were rinsed with PBS and
fixed with 2% glutaraldehyde in phosphate buffer and processed for cryo-
sectioning and immunogold electron microscopy. Cells were labeled with
antibodies directed against ARF6 and biotin. For controls, cells infected
with vector virus were incubated with HRP (4 mg/ml) for 30 min in serum-
free media, followed by washes with PBS containing 0.2% BSA and 5 mM
glucose. Cells were chilled, biotinylated as described above, and then pro-
cessed for cryoimmunogold electron microscopy and labeling with anti-
bodies against HRP and biotin.
 
Expression of ARF6(T27N) Using Vaccinia Virus
 
The ARF6(T27N)-pTM3 plasmid was generated by PCR amplification of
hemagglutinin (HA)-tagged ARF6(T27N) cDNA (Peters et al., 1995)
with sequences encoding NcoI and BglII restriction sites at the NH
 
2
 
- and
COOH-terminal ends, respectively, that was then cloned into the vaccinia
expression vector pTM3 (Fuerst et al., 1988). The resulting plasmid was
stably integrated into vaccinia virus by homologous recombination as pre-
viously described (Anusbel et al., 1987). HEK 293 cells were then coin-
fected with recombinant viruses that encode for ARF6(T27N) and T7
RNA polymerase (virus 7.3) for 9 h as previously described (Fuerst et al.,
1988). Cells were fixed and processed for cryosectioning and immunogold
labeling as described below.
 
Analysis of HRP Distribution
 
TRVb-1 cells were infected with either vector virus alone or with recombi-
nant virus encoding wild-type ARF6, ARF6(Q67L), or ARF6(T27N). At
4.5 h after infection, cells were incubated with 5 mg/ml HRP for 5 or 60
min in Hams F12 serum-free media containing 0.2% BSA. The cells were
quickly rinsed with media followed by fixation with 2% glutaraldehyde in
0.1 M phosphate buffer. Cells were scraped gently from the dish and col-
lected in 0.1 M phosphate buffer containing 0.2% glutaraldehyde and then
processed for embedding and cryosectioning (see below). Ultrathin cryo-
sections were double labeled with antibodies directed against ARF6 and
HRP as described below.
 
Cryoimmunogold Electron Microscopy Procedures
 
Cell monolayers on petri dishes were fixed at room temperature in 2%
paraformaldehyde in 0.1 M phosphate buffer for 12 h, or with 2% glutaral-
dehyde for 1 h. Cells were scraped and collected into 0.1 M phosphate
buffer containing 0.2% of paraformaldehyde and then processed for ul-
trathin cryosectioning as previously described (Peters et al., 1991). 45-nm
cryosections were cut at 
 
2
 
125
 
8
 
C using diamond knives (Drukker Cuijk,
The Netherlands) in an Utracryomicrotome (Leica Aktiengesellschaft,
Vienna, Austria) and transferred with a mixture of sucrose and cellulose
onto formvar-coated copper grids (Liou et al., 1996). The grids were
placed on 35-mm petri dishes containing 2% gelatin, and immunolabeling
of sections was done as previously described (Raposo et al., 1997). In
brief, sections were incubated with primary antibody for 45 min, washed,
and then incubated with protein A–gold (EM Lab., Utrecht University)
for 30 min. For double labeling experiments labeling with a second anti-
body followed by protein A–gold was carried out consecutively after la-
beling with the first antibody. For colocalization experiments to rule out
the possibility that the absence of apparent colocalization could be due to
the first antibody preventing the binding of the second antibody, we com-
pared the density of labeling of these antibodies in single immunolabeling
procedure first. No significant blocking effect was observed. Labeled sec-
tions were viewed with a JOEL 1010 electron microscope at 80 kV.
 
Quantitation of Immunogold Labeling
 
Quantitative evaluations were carried out on ultrathin cryosections of the
ARF6 wt, mutants, and controls. Cross sections of 25 cells that were la-
beled for anti-ARF6–10-nm gold (Table I) or with ARF6–10 nm gold and
HRP–5 nm gold (Table II) were randomly chosen and photographed and
the negatives were printed at a final magnification of 25,000
 
3
 
. Gold parti-
cles located at no more than 20 nm from a visible membrane structure
were assigned to the structure listed. ARF6 label was assigned to the
plasma membrane/invaginations and to pericentriolar vesicles and tubules
(Table I). For the assessment of size the 200-nm bar on the electron mi-
crograph was used as an arbitrary line. The criteria for colocalization was
as follows: (
 
a
 
) at least one small and one large gold particle should be
present within the vesicle and (
 
b
 
) colabeling artifacts of small and large
particles that were 
 
,
 
10 nm from each other were seldom seen and ex-
cluded from quantitation.
 
Results
 
Localization of ARF6 in CHO Cells
 
In a previous study on the subcellular distribution of epitope-
tagged ARF6 at the ultrastructural level in HEK 293 fibro-
blasts, ARF6 was shown to be present on the plasma mem-
brane and on intracellular compartments (Peters et al.,
1995). However, high levels of protein were expressed us-
ing the calcium phosphate method of transfection, fol-
lowed by analysis of expressed proteins 48 h after transfec-
tion. In this study, we have investigated the distribution of
wild-type ARF6 in CHO cells using the Sindbis virus ex-
pression system, which allows for protein detection at rela-
tively shorter intervals after virus infection. Therefore, we
could analyze the subcellular distribution of untagged
ARF6 at varying levels of protein expression, by the tech-
nique of cryoimmunogold electron microscopy using anti-
bodies directed against ARF6. At relatively high levels of
ARF6 expression, implicit by higher amounts of gold la-
beling, the plasma membrane exhibited tortuous invagina- 
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tions resembling membrane alterations seen in cells express-
ing the GTPase-defective mutant, ARF6(Q67L). 50–60%
of gold label was seen along these invaginations (Fig. 1 
 
A
 
,
Table I). Gold label was also seen on intracellular vesicles,
some of which were peripherally distributed while most
were localized around the pericentriolar region of the cell
(see below). About 20% of the ARF6 label was found
scattered throughout the cytosol. Interestingly, in cells ex-
pressing ARF6 at the lowest detectable level, gold label
was seen predominantly on vesicles around the centriole,
juxtaposed to the TGN (Fig. 1 
 
B
 
, Table I), whereas 
 
,
 
15%
of the label was detected on the plasma membrane. Also,
the plasma membrane of these cells was relatively unper-
turbed compared with the surface of cells expressing rela-
tively higher levels of ARF6. Thus, ARF6 localization in
CHO cells is predominantly intracellular; with increased ex-
pression, the cell phenotype resembles that observed in
cells expressing the GTPase-defective mutant, most likely
due to sequestration of factors required for GTP hydroly-
sis by overexpressed protein. The ARF6-labeled intracel-
lular vesicles were small and ranged in diameter from 60 to
200 nm and resembled the recycling endosomal compart-
ment previously described in CHO cells (Yashimoro et al.,
1984; Johnson et al., 1996). This compartment is distinct
from the TGN, late endosomes, or lysosomes. These find-
ings were unexpected since a previous study that used sub-
cellular fractionation procedures, had found endogenous
ARF6 to be localized exclusively to the plasma membrane
of CHO cells (Cavenagh et al., 1996). This point is addressed
further below.
 
Ultrastructural Characterization of Membrane 
Rearrangements Induced by Expression of ARF6:GTP 
and ARF6:GDP Mutants
 
On analysis of the distribution of the ARF6(Q67L), the
GTP-bound mutant, consistent with previous findings in
HEK 293 cells, we observed that the mutant protein local-
ized almost exclusively to discrete sites on the plasma
membrane of CHO cells, in regions that exhibited numer-
ous membrane folds that lacked clathrin-coated pits and to
sac-like structures (see Table I). To determine whether
these sac-like structures were cross-sections through plasma
membrane folds or were internalized vesicular compart-
ments, we tested for their accessibility to cell surface bi-
otin. For these experiments, cells expressing ARF6(Q67L)
were treated with sulpho-NHS-biotin, a biotinylating agent,
at 4
 
8
 
C, fixed, and then double labeled with antibodies
against ARF6 and biotin. Biotin couples to the entire ac-
cessible surface of the fibroblasts. In control cells, labeling
for biotin was observed on the plasma membrane and in
some invaginations along the cell periphery (Fig. 2 
 
A
 
). In
cells expressing ARF6(Q67L), the membrane folds and
sac-like structures that labeled positively for ARF6, also
labeled with antibiotin antibodies (Fig. 2 
 
B
 
). This accessi-
bility to surface biotinylation suggests that these structures
were indeed sections through plasma membrane folds/in-
vaginations and hence continuous with the extracellular
environment.
In cells expressing the GTP binding–defective mutant,
ARF6(T27N), ARF6-positive vesicles were observed around 
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the pericentriolar region of the cell whereas the plasma
membrane exhibited little gold label (Fig. 3, Table I). No-
tably, these vesicles did not exhibit the prominent coat
structure along their cytoplasmic face, as previously ob-
served by Peters et al. (1995) in HEK 293 cells (see be-
low). Further, the ARF6(T27N) vesicles in CHO cells
were less densely packed and were present as much
smaller clusters as compared with the grape-like clusters
seen in HEK 293 cells. These differences may reflect differ-
ences in cell types. The ARF6(T27N) compartment was in-
accessible to surface biotinylation clearly indicating that it
was intracellular. Morphologically, it resembled an ampli-
fied perinuclear endocytic compartment observed in cells
expressing wild-type protein.
 
Characterization of the ARF6
Intracellular Compartment
 
Double immunogold labeling of cells expressing wild-type
ARF6, with antibodies directed against ARF6 and the trans-
ferrin receptor (Tfn-R), revealed that much of the ARF6
and Tfn-R label was either colocalized or found on vesi-
cles that were either docked or in close proximity of each
other at the pericentriolar region of the cell (Fig. 4 
 
A
 
).
This compartment appeared as a compact fenestrated net-
work of vesicles and tubules that ranged from 60 to 200 nm
in diameter. The intracellular ARF6 compartment was
amplified in cells expressing the ARF6(T27N) mutant and
as seen in wild-type expressing cells, colocalization of ARF6
and Tfn-Rs, was also seen in cells expressing the ARF6
Figure 1. (A and B) Local-
ization of wild-type ARF6.
CHO cells expressing wild-
type ARF6 were fixed and
processed for ultrathin cryo-
sections. Sections were la-
beled with anti-ARF6 poly-
clonal antibody followed by
protein A–gold (10 nm). (A)
ARF6 localizes to the plasma
membrane and intracellular
vesicles. (B) At relatively
lower levels of expression,
ARF6 localizes predomi-
nantly to intracellular vesi-
cles that are situated near the
TGN.  i, invaginations; p,
plasma membrane; er, endo-
plasmic reticulum; m, mito-
chondria; G, Golgi complex;
TGN, trans-Golgi network; e,
endosome; c, centriole; n, nu-
cleus. Bar, 200 nm.  
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mutant (Fig. 4 
 
A
 
, 
 
inset
 
). Approximately 90% of the Tfn-Rs
were intracellular in cells expressing ARF6(T27N). When
analyzed in HEK 293 cells, most of the Tfn-Rs were found
in ARF6-containing vesicles, although in these cells, the
ARF6/Tfn-R–containing vesicles exhibited an electron-
dense coat structure along their cytoplasmic face (Fig. 4
 
B
 
). Interestingly, Tfn-R–positive compartments that were
negative for ARF6 and vice versa were also observed in
cells expressing the wild-type and mutant ARF6 proteins,
suggesting that ARF6 may not be present on Tfn-R–con-
taining compartments throughout the Tfn-R cycle. Also,
the existence of ARF6-positive vesicles that do not label
with the Tfn-R implies that ARF6 may have a broader sub-
cellular distribution than the Tfn-R–labeled recycling com-
partment. A statistical analysis of the number of vesicles
that labeled with both proteins, as opposed to those that
labeled with each of them, was not feasible because of the
low numbers of gold particles per vesicle.
Since we had previously shown that expression of
ARF6(T27N) decreases the efficiency of Tfn recycling, we
were prompted to examine whether proteins implicated in
Tfn recycling colocalized with the ARF6 compartment.
Cellubrevin, a member of the synaptobrevin/VAMP fam-
ily of SNARES, is present on Tfn-R–containing vesicles in
fibroblasts (McMohan et al., 1993) and tetanus toxin-
mediated cleavage of cellubrevin impairs the recycling of
Tfn-R–containing vesicles in CHO cells (Galli et al., 1994).
Fig. 5 
 
A
 
 shows the distribution of Tfn-Rs and cellubrevin
in the pericentriolar endosomal compartment. We com-
pared the distribution of ARF6 with that of cellubrevin.
For these studies, cells expressing either wild-type ARF6
or ARF6(T27N) were double labeled with antibodies di-
rected against ARF6 and cellubrevin. We found that cellu-
brevin-labeled, ARF6-positive vesicles in cells expressing
wild-type ARF6 (Fig. 5 
 
B
 
) or ARF6(T27N; data not shown)
and most of the colocalization was concentrated at the
pericentriolar region of the cell. Double labeling for cat-
ion-dependent mannose-6-phosphate receptor (MPR; Fig
5 
 
B
 
) a late endosome marker, and LAMP-1 (not shown)
Figure 3. Localization of ARF6(T27N). Cells expressing ARF6
(T27N) were processed and labeled as described for Fig. 1. The
ARF6 mutant localizes predominantly to clusters of vesicles jux-
taposed to the TGN at the perinuclear region of the cell. G,
Golgi. Bar, 200 nm. 
 
Table I. Quantitation of the Intracellular Distribution of
Wild-type and Mutant ARF6 Proteins
 
Cells transfected with
Plasma membrane/
invaginations
Pericentriolar vesicles
and tubules
 
ARF6 (low expression) 4 38
ARF6 (high expression) 125 66
ARF6(Q67L) 159 34
ARF6(T27N) 18 163
 
CHO cells on monolayers expressing ARF6 wild-type or mutant proteins were fixed
and processed for cryoimmunogold labeling and labeled waith anti-ARF6 antisera fol-
lowed by protein A–10-nm gold. The data represents an average of 10-nm gold parti-
cle count obtained from 25 cells.
Figure 2. (A and B) Biotinylation of the surface of cells express-
ing ARF6(Q67L). Cells were either infected with vector virus
and incubated with HRP for 10 min (A) or infected with recombi-
nant virus encoding ARF6(Q67L) (B), and then incubated with
sulfo-NHS-biotin and processed for immunolabeling. Sections
were labeled first with an antibiotin antibody followed by protein
A–gold (15 nm), and then with an antibody against HRP fol-
lowed by protein A–gold (5 nm, A), or with antibody against
ARF6 followed by protein A–gold (10 nm, B). (A) Only the
plasma membrane and cross-sections across membrane invagina-
tions were labeled with biotin. Early endocytic structures labeled
with HRP were inaccessible to biotin. (B) In ARF6(Q67L)-
expressing cells, plasma membrane invaginations were accessible
to biotin (arrowheads) and thus are in continuity with the extra-
cellular milieu. i, invaginations; p, plasma membrane; e, endo-
somes. Bar, 200 nm. 
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and LAMP-3 (Fig. 5 
 
D
 
), markers for lysosomes, revealed
little or no labeling of any of these markers in ARF6-posi-
tive vesicles. Furthermore, the ARF6-positive vesicles did
not colocalize with 
 
g
 
-adaptin and other Golgi and endo-
plasmic reticulum markers (data not shown). Taken to-
gether, these findings indicate that intracellular ARF6 lo-
calizes to the perinuclear endosomal recycling compartment
in CHO cells.
Figure 4. (A and B) Trans-
ferrin receptors localize to
ARF6 and ARF6(T27N)
vesicles. CHO cells (A) or
HEK 293 cells (B) expressing
ARF6 (A) and ARF6(T27N)
(A, inset and B) were fixed
and processed for cryoim-
munogold labeling. Sections
were labeled first with the
anti-ARF6 antibody followed
by protein A–gold (A, 15 nm;
B, 10 nm) and then with the
anti–Tfn-R antibody followed
by protein A–gold (A, 10 nm;
B, 5 nm). ARF6 and Tfn-R
labeling is seen on the same
vesicle (arrows) or on vesi-
cles in near proximity of each
other. Arrowhead indicates a
clathrin-coated pit. c, centri-
ole; p, plasma membrane. Bar,
200 nm. 
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Comparative Intracellular Distribution of ARF6 and 
Endocytosed HRP
 
We have compared the distribution of ARF6 and its mu-
tants, relative to that of the endocytic tracer, HRP. HRP
has been extensively used as a morphological and bio-
chemical marker in endocytosis assays. Swanson et al.
(1987) have shown that HRP is taken up by clathrin-
dependent endocytosis in activated peritoneal macro-
phages. In BHK fibroblasts, most of the internalized HRP
was shown to be delivered to lysosomes, while a small pro-
portion recycled back to the cell surface (Griffiths et al.,
1989). To analyze the distribution of endocytosed HRP,
CHO cells were incubated with serum-free media contain-
ing HRP, quickly rinsed, fixed, and then processed for im-
munogold labeling with antibodies against HRP. With 5
min of HRP uptake, numerous early endocytic structures
along the cell periphery that varied from tubular elements
to large vesicles and that ranged from 50 to 400 nm in di-
ameter were loaded with HRP (data not shown). HRP la-
beling was also detected in clathrin-coated vesicles, indi-
cating that in CHO cells HRP was being internalized via
clathrin-dependent in addition to clathrin-independent path-
ways. With 60 min of continuous HRP uptake, gold label-
ing became apparent in large vacuoles (
 
,
 
1 
 
m
 
M in diame-
ter), some of which contained internal membrane and
resembled multivesicular late endosomal and lysosomal
compartments (Fig. 6). In addition, smaller vesicles in the
perinuclear region that were 
 
z
 
50–60 nm in diameter were
also labeled for HRP (Fig. 6). These latter vesicles may be
recycling endocytic vesicles that regurgitate HRP back to
the extracellular environment. Analysis by confocal immu-
nofluorescence microscopy of the distribution of Tfn-Rs
relative to fluorescein-conjugated HRP revealed that only
a subpopulation of these makers (
 
<
 
15%) was colocalized
at the perinuclear compartment (data not shown).
To determine the subcellular distribution of ARF6 rela-
Figure 5. ARF6 colocalizes with cellubrevin but not with MPR or Lamp. CHO cells expressing wild-type ARF6 were doubled labeled
with an anticellubrevin antibody (15 nm gold), followed by anti–Tfn-R antibody (A, 10 nm), or with an anti-ARF6 antibody (5 nm gold)
followed by an anticellubrevin antibody (B, 10 nm gold). Arrows show clear examples of labeling for cellubrevin on ARF6-containing
vesicles. HEK-293 cells expressing ARF6 (T27N) were double labeled with antibodies against ARF6 (5 nm gold) followed by labeling
with antisera against MPR (C, 10 nm gold), or with anti-ARF6 antibody (10 nm gold) followed by anti–Lamp-3 antibody (D, 5 nm gold).
MPR and Lamp-3 labeling was done in 293 cells due to low cross-reactivity in CHO cells. c, centriole. Bar, 200 nm. 
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tive to HRP under conditions of both short and more pro-
longed exposure to the tracer, cells expressing either wild-
type ARF6 or its mutants defective in either GTP binding
or hydrolysis were incubated with HRP for 5 or 60 min,
fixed, processed for cryoimmunoelectron microscopy, and
then labeled with antibodies directed against ARF6 and
HRP. In cells expressing wild-type ARF6, no colocaliza-
tion between these markers was observed with 5 min of
HRP uptake (Table II), and ARF6-positive vesicles were
clearly distinct from the numerous early endocytic struc-
tures that labeled with HRP. This strongly suggests that
ARF6-positive vesicles were not early endosomes. On more
prolonged exposure to HRP however, 
 
,
 
10% of ARF6-
positive vesicles were also labeled with HRP (Fig. 7). In
cells expressing ARF6(Q67L), the GTPase-defective mu-
tant, HRP label appeared to be significantly lower and ex-
hibited 
 
,
 
50% of gold labeling compared with control
cells, thus indicating that the amount of HRP internalized
into these cells was significantly reduced. This is similar to
what was observed previously for the internalization of
transferrin in CHO cells on expression of ARF6(Q67L;
D’Souza-Schorey et al., 1995). The reduced efficiency of
endocytosis in these cells may most likely be due to the
dramatic alterations at the plasma membrane induced on
expression of the GTPase-defective mutant. Labeling for
HRP was restricted to small 80–100-nm vesicles at the pe-
riphery (Fig. 8 
 
A
 
), and on occasion, some label was also
seen “entrapped” in membrane invaginations, but in 95%
of these cells the ARF6-positive plasma membrane struc-
tures were devoid of HRP labeling. In cells expressing the
GTP binding–defective mutant, ARF6(T27N), similar to
what was observed with wild-type ARF6, no colocalization
between the ARF6-positive and HRP-positive vesicles
was observed with a short 5-min exposure to HRP (see Ta-
ble II). However, after 60 min of HRP uptake, z10–15%
of ARF6-positive vesicles that accumulate at the pericen-
triolar region of the cell also labeled for HRP (Fig. 8 B).
Vesicles that label for ARF6(T27N), but not HRP, may be
preformed vesicles or vesicles that are not accessible to
HRP. These findings indicate that at some step after inter-
nalization, most likely at the recycling endosome, a small
proportion of HRP has access to ARF6-positive vesicles.
Based on the these observations and the findings de-
scribed above on the colocalization of ARF6 with Tfn-Rs
and cellubrevin, we propose that ARF6 localizes to and
regulates the transport of recycling vesicles at the pericen-
triolar region of CHO cells to the plasma membrane.
Discussion
In this study we have undertaken a characterization of mem-
brane rearrangements induced on expression of wild-type
Figure 6. HRP distribution
in CHO cells. Cells mock in-
fected with the vector virus,
were incubated with HRP for
60 min, fixed and processed
for ultrathin cryosections.
Sections were labeled with
an anti-HRP antibody fol-
lowed by protein A conju-
gated to gold particles (5
nm). The figure shows HRP
labeling in the trans-Golgi
region of the cell on small
and multivesicular endocytic
structures (e). Bar, 200 nm.The Journal of Cell Biology, Volume 140, 1998 612
ARF6 and its mutant derivatives defective in either GTP
binding [ARF6(T27N)] or hydrolysis [ARF6(Q67L)]. Pre-
viously, we have shown that ARF6 localizes to the plasma
membrane and intracellular compartments (D’Souza-
Schorey et al., 1995; Peters et al., 1995). Now we show that
at relatively low levels of expression, ARF6 in CHO cells,
is localized almost exclusively to an intracellular pericen-
triolar compartment. This compartment is morphologi-
cally reminiscent of a recycling endosomal compartment
that has been previously described (Yashimoro et al., 1984;
Griffiths et al., 1989; Connolly et al., 1994; Ghosh and
Maxfield, 1995). The recycling compartment appears as a
collection of vesicles and tubules at the pericentriolar re-
gion of the cell and is distinct from the larger sorting endo-
somes and the Golgi complex and is enriched in recycling
receptors such as the transferrin and LDL receptor. The
transfer of recycling membrane from the pericentriolar re-
gion to the plasma membrane is likely to involve the for-
mation of fusogenic recycling intermediates, although these
have not been characterized. The colocalization of ARF6
with Tfn-Rs in vesicles and tubules in the pericentriolar re-
gion suggests that most of the intracellular ARF6 resides
in the recycling endosomal compartment. The recycling
compartment has also been characterized as a tubular net-
work located around the pericentriolar region of other cell
types including AtT20 cells and HEp2 cells (Hopkins et al.,
1990; Tooze and Hollinshead, 1991). Whether such a com-
partment serves as a passive vehicle for the transport of
molecules to the cell surface, or whether there may be
other functions associated with the recycling compartment
has been a subject of investigation. The isolation of a CHO
mutant cell line (12-4) in which the exit of receptors from
the recycling compartment is delayed and that of bulk
membrane is normal, suggests that the recycling compart-
ment may have a sorting function (Presley et al., 1993).
Furthermore, there is mounting evidence for communica-
tion between the TGN and the recycling endosomal com-
partment (Geuze and Morre, 1991; Futter, 1995; Leitinger et
al., 1995; Sariola et al., 1995; Ulrich, 1996).
Our findings on the subcellular distribution of ARF6 in
CHO cells are in marked contrast to observations made by
Cavenagh et al. (1996), who reported that ARF6 was lo-
calized exclusively to the plasma membrane of CHO cells.
In their study, early endosomes were identified by endocy-
tosis of HRP for 10 min. We have compared the intracellu-
lar distribution of ARF6 relative to that of HRP. Interest-
ingly, when we determined the distribution of HRP after a
short 5-min exposure to the ligand and that of wild-type
ARF6, no colocalization was observed indicating that ARF6
was not present on newly endocytosed vesicles. With a
more prolonged exposure however, HRP does appear to
have access to only a small proportion of ARF6-positive
vesicles around the pericentriolar region of the cell that
likely represent recycling vesicles that are destined toward
the plasma membrane. Based on our findings, it is unlikely
that ARF6-positive compartments would be loaded with
HRP under the experimental conditions used by Cave-
nagh et al. (1996), and even if it did, the fraction of ARF6-
positive vesicles that contain HRP is so minor that it may
have escaped detection by Western blot analysis. Further-
more, the latter study used sucrose density gradients and
free flow electrophoresis for separation of endosomes
Figure 7. ARF6 colocalize
with HRP only on prolonged
exposure to the tracer. Cells
expressing wild-type ARF6
were incubated for 60 min
with HRP, fixed, and then
processed for cryoimmu-
nogold labeling. Samples
were labeled with an anti-
ARF6 polyclonal antibody
followed by protein A–gold
particles (10 nm) and then
with an anti-HRP antibody
followed by protein A–gold
particles (5 nm). With pro-
longed exposure to HRP
some colocalization (<10%)
with ARF6-positive vesicles
was observed (arrow, inset at
higher magnification). e, en-
dosomes; m, mitochondria; n,
nucleus;  ne, nuclear enve-
lope; p, plasma membrane.
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from Golgi complex, ER, and plasma membrane fractions.
It is possible that recycling endocytic vesicles that fuse
with the plasma membrane may cofractionate with the
plasma membrane fraction, when using a separation pro-
cedure based on the electrophoretic mobility of mem-
branes.
The colocalization of ARF6 with Tfn-Rs and cellubrevin
at the pericentriolar region, strongly supports the conten-
tion that ARF6 localizes to the recycling endosomal com-
partment. Cellubrevin has been localized to Tfn-containing
vesicles in fibroblasts (McMohan et al., 1993). In addition,
tetanus toxin cleavage of cellubrevin decreases the rate of
Tfn release in CHO cells (Galli et al., 1994), a phenotype
shared by the dominant negative mutant of ARF6, ARF6
(T27N). The presence of peripherally distributed Tfn-R– and
cellubrevin-positive compartments that are devoid of the
ARF6 label may likely represent Tfn-R endosomes on the
inward leg of the Tfn cycle. We also attempted to compare
the distribution of Rab4 and Rab11 with ARF6; unfortu-
nately we were not able to localize endogenous Rab pro-
teins. It would be interesting to determine whether ARF6
would function downstream of Rab 11 in the endosomal
recycling pathway. Also of interest are the striking differ-
ences in the morphological characteristics of the ARF6
(T27N) compartment in the different cell types examined.
The distinct “coat” structure seen on the cytoplasmic
phase of the ARF6(T27N)-containing vesicle in HEK 293
cells was not as apparent in CHO cells. Why such differ-
ences exist between cell types is unclear at present. The
ARF6(T27N)-coated vesicles do not label with antibodies
directed against clathrin or b-COP (Peters et al., 1995).
The presence of 100-nm nonclathrin-coated buds on Tfn-
R–positive endosomes also have been described in A431
cells (Stoorvogel et al., 1996). The recycling of coated vesi-
cles and its subsequent fusion with the plasma membrane
would require “uncoating,” a process that may be trig-
gered by activation/nucleotide exchange of ARF6. In this
regard, studies in sec7 mutant Saccharomyces cerevisiae
cells have indicated that in individual ARFs may perform
distinct functions in vesicular coat dynamics, namely coat
recruitment (budding) and vesicle uncoating, which pre-
cede vesicle docking and fusion (Deitz et al., 1996).
More recently, ARF6 has been shown to cofractionate
along with chromaffin granules in adrenal chromaffin cells
and has been implicated in regulated exocytosis (Galas et al.,
1997), although a detailed morphological characterization
of ARF6 in these cells has not been reported. Hence, it ap-
pears that the subcellular localization of ARF6 may be cell
type specific. Therefore, the question that arises is what is
the underlying function of ARF6 in various cell types. It
is possible that ARF6 serves to regulate the outward flow
of membrane traffic and thereby modulate the shape and
Figure 8. (A and B) HRP distribution in cells expressing
ARF6(Q67L) and ARF6(T27N). Cells expressing ARF6(Q67L)
(A) and ARF6(T27N) (B) were incubated with HRP for 60 min,
fixed, and then processed for ultrathin cryosections. Sections
were first labeled with anti-ARF6 antibody followed by protein
A–conjugated gold particles (10 nm) and then with an anti-HRP
antibody followed by protein A–gold particles (5 nm). (A) Typi-
cally, in ARF6 (Q67L)-expressing cells, HRP labeling was re-
stricted to small vesicles at the periphery (e). Membrane invagi-
nations were observed even at very low levels of ARF6(Q67L)
expression, implicit by low numbers of gold particles on the mem-
brane. (B) A small population of ARF6(T27N)-positive vesicles
were also labeled with HRP (arrows). i, invaginations; e, endo-
somes; p, plasma membrane. Bar, 200 nm.
Table II. Quantitation of HRP Label in Pericentriolar
ARF6-positive Vesicles Relative to Other Small Vesicles
(,200-nm Diameter)
Cells transfected with
Small vesicles
(,200 nm)
ARF6-positive
vesicles
Minutes post uptake
56 056 0
ARF6 34 173 0 12
ARF6(Q67L) 21 112 0 0
ARF6(T27N) 59 189 0 28
Vector 89 342 22
CHO cells on monolayers expressing ARF6 wild-type or mutant proteins were incu-
bated with HRP as described in Materials and Methods. Monolalyers were quickly
rinsed, fixed, and processed for cryoimmunogold labeling and doubled-labeled with
antibodies directed against ARF6 followed by protein A–10-nm gold and against HRP
followed by protein A–5-nm gold as described in Materials and Methods. The data
represents an average of 5-nm gold particle count obtained from 25 cells for each con-
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structural organization of the plasma membrane. In CHO
cells, using quantitative fluorescence microscopy it has been
demonstrated that C6-NBD-SM (N-[N- (7-nitro-2,1,3-ben-
zoxadiolol-4)-e-aminihexanoyl] sphingosyl phosphorycho-
line), a bulk plasma membrane marker, transits the endocytic
system in a manner that is kinetically and morphologically
identical to that of recycling receptors (Mayor et al., 1993).
Thus, in these cells, ARF6 may also serve to regulate the
exit of bulk membrane. Conceivably, the rates of such a
process would be dramatically altered during cellular pro-
cesses that would require a remodeling of the plasma mem-
brane such as diapedesis, cell spreading, and metastasis.
Based on our observations, it is tempting to speculate how
ARF6 could control membrane recycling via its nucleotide
cycle (Fig. 9). We propose that nucleotide exchange on
ARF6 drives the uncoating/transport and subsequent fu-
sion of ARF6-positive intracellular recycling vesicles with
the plasma membrane. At the surface, the hydrolysis of
bound GTP would allow either (a) the internalization of
membrane-bound ARF6 via the endocytic pathway or (b)
the release of ARF6 from the membrane into the cytosol.
In the latter case, cytosolic ARF6:GDP would have to be
recruited onto the recycling endosomal compartment and
with subsequent nucleotide exchange on ARF6, another
cycle follows. Although we did not observe any colocaliza-
tion of ARF6 with HRP loaded early endocytic structures,
at this point we cannot rule out the possibility that ARF6
could indeed localize to incoming vesicles that are not ac-
cessible to HRP and that later on by the process of endo-
some fusion become HRP and Tfn-R positive.
The model described above explains the phenotypes ob-
served by expression of ARF6 mutants. On expression of
ARF6(T27N), the mutant defective in nucleotide exchange,
an accumulation of vesicles at the perinuclear region of the
cell and an inhibition of recycling of ligands to the cell sur-
face was observed (D’Souza-Schorey et al., 1995). On ex-
pression of ARF6(Q67L), the mutant defective in GTP
hydrolysis, an accumulation of membrane at the cell sur-
face was observed along with the depletion of intracellular
endosomal compartments (Peters et al., 1995; this study).
The lack of coated vesicle formation along the ARF6-
induced membrane invaginations may explain, in part, the
decrease in efficiency of clathrin-dependent endocytosis
observed in these cells. Reconstitution of transferrin recy-
cling in streptolysin O–permeabilized CHO cells has shown
that fusion of recycling endosomal vesicles with the plasma
membrane does not require GTP hydrolysis, is brefeldin A
insensitive, and is stimulated by GTPgs at suboptimal con-
centrations of cytosol (Martys et al., 1996). Furthermore, it
has been reported that Tfn-R–positive recycling vesicles in
the perinuclear region of the cell do not exhibit a tubular
morphology on treatment with the drug brefeldin A, as do
the early endosomal compartments from which they are
derived (Daro et al., 1996). These reports are consistent
with our observations that ARF6 distribution is brefeldin
A insensitive (Peters et al., 1995) and that its redistribu-
tion to the plasma membrane does not require GTP hy-
drolysis. The stimulation of vesicle fusion with the plasma
membrane by GTPgS, besides endosomal membrane recy-
cling, is also characteristic of regulated secretion (Gomp-
erts et al., 1990). The lack of requirement of GTP hydrolysis
for fusion of endosomal recycling vesicles and of secretory
vesicles during regulated secretion with the plasma mem-
brane distinguishes these processes from constitutive exo-
cytosis from the TGN to the cell surface since the latter is
inhibited by GTPgS (Miller and Moore, 1991). It is possi-
ble that ARF6 could promote the generation of fusogenic
lipids at the plasma membrane. ARF6 had been shown to
stimulate phospholipase D (PLD) activity in vitro (Mas-
senburg et al., 1995). PA a product of PLD metabolism
stimulates the synthesis of phosphatidyl inositol 4,5,bis-
phosphate (PIP2; Loyens and Anderson, 1996). Thus, via
its effects on phospholipid metabolism, the maintenance
of ARF6 in the GTP state would result in the accumula-
tion of charged lipids such as PIP2 at the cell periphery.
PIP2 has also been shown to stimulate actin polymeriza-
tion; indeed actin polymerization at the cell surface is in-
duced on expression of ARF6(Q67L), the GTP-bound mu-
tant of ARF6 (Radhakrishna et al., 1996; D’Souza-Schorey
et al., 1997). We are currently establishing in vitro assays
to investigate these possibilities.
It is clear from our studies that ARF6 localizes to an in-
tracellular tubulovesicular membrane recycling compart-
ment in CHO cells. Furthermore, our findings indicate that
the ability of ARF6 to cycle between its GTP- and GDP-
bound conformation is critical for maintaining the integ-
rity of peripheral membrane organization and trafficking.
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Figure 9. Model for the ARF6:GTP/GDP cycle in CHO cells.
Nucleotide exchange on ARF6 drives the transport and subse-
quent fusion of recycling vesicles with the plasma membrane. Hy-
drolysis of bound GTP at the cell surface allows the internaliza-
tion of ARF6 via membrane vesicles inaccessible to HRP or the
release of ARF6 from the membrane into the cytosol. Cytosolic
ARF6 would have to be recruited back onto the recycling com-
partment (R.C.) for another nucleotide cycle to ensue.D’Souza-Schorey et al. ARF6 Targets Recycling Vesicles to the Plasma Membrane 615
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